乳腺癌和中乳腺霍奇金淋巴瘤:多学科讨论
Ruben Touati1, Lea Pauly2, Fabien Reyal2
1Department of Radiation Oncology, Institut Curie Hospital, Paris, France.
Clinical breast cancer
|July 7, 2023
概括
现代霍奇金 (Modern Hodgkin) 是一个现代的霍奇金.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 手术瘤学手术瘤学
背景情况:
- 有效的霍奇金淋巴瘤 (HL) 治疗改善了生存率,但增加了第二种癌症的风险,特别是乳腺癌.
- 以往HL的胸部照射通常会对随后的乳腺癌进行乳腺保护手术 (BCS) 的禁忌.
- 现代,低剂量辐射对二次乳腺癌风险的影响尚不清楚.
研究的目的:
- 审查HL治疗后乳腺癌的患病率.
- 评估HL幸存者的逆侧乳腺癌风险.
- 在这个人群中讨论乳房保护手术 (BCS) 和重建的可行性.
主要方法:
- 审查主要的临床试验和最近的发展.
- 辐射瘤学家和外科医生之间的讨论.
- 对HL幸存者的二次恶性瘤数据的分析.
主要成果:
- 霍奇金淋巴瘤幸存者面临着二次性乳腺恶性瘤的风险增加.
- 不断发展的辐射技术对这种风险的确切影响需要进一步调查.
- 关于逆侧癌症风险和BCS可行性的数据至关重要.
结论:
- 优化HL治疗需要平衡有效性与二次乳腺癌等长期风险.
- 必须进行多学科讨论,以完善HL幸存者的乳腺癌管理指南.
- 需要进一步的研究来澄清现代HL治疗后保护乳腺方法的安全性.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Immunotherapy
573
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
573
Lymphatic Vessels and Lymph Transport
3.7K
Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
3.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


